Citizens Advises Enovis on Sale of Dr. Comfort to Promus Equity Partners

Reuters

Oct 20, 2025

Citizens Advises Enovis on Sale of Dr. Comfort to Promus Equity Partners

Enovis Corporation has completed the sale of its subsidiary, Dr. Comfort, to Promus Equity Partners. Dr. Comfort, founded in 2002 and based in Mequon, Wisconsin, is a leading manufacturer and provider of orthopedic and diabetic footwear, including shoes, inserts, socks, slippers, sandals, and compression hosiery. The transaction was supported by Citizens Capital Markets & Advisory, which acted as the exclusive financial advisor to Enovis. Promus Equity Partners expressed enthusiasm about partnering with Dr. Comfort to further its mission of improving the lives of people with diabetes and other foot-related conditions.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Citizens Financial Group Inc. published the original content used to generate this news brief on October 20, 2025, and is solely responsible for the information contained therein.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

1
2
3
4
5
6
7
8
9
10

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/news/2576857633"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2576857633\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/2576857633?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-10-20 21:26","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2576857633","market":"us","top_or_hot":-1,"title":"Citizens Advises Enovis on Sale of Dr. Comfort to Promus Equity Partners","media":"Reuters","content":"<html xmlns=\"http://www.w3.org/1999/xhtml\" xmlns:newsg2=\"http://iptc.org/std/nar/2006-10-01/\" xmlns:xhtml=\"http://www.w3.org/1999/xhtml\"><head><title>\n      Citizens Advises Enovis on Sale of Dr. Comfort to Promus Equity Partners\n    </title></head><body><div xmlns:xsd=\"http://www.w3.org/2001/XMLSchema\" xmlns:xsi=\"http://www.w3.org/2001/XMLSchema-instance\">\n<p>\n        <a href=\"https://laohu8.com/S/ENOV\">Enovis Corporation</a> has completed the sale of its subsidiary, Dr. Comfort, to Promus Equity Partners. Dr. Comfort, founded in 2002 and based in Mequon, Wisconsin, is a leading manufacturer and provider of orthopedic and diabetic footwear, including shoes, inserts, socks, slippers, sandals, and compression hosiery. The transaction was supported by Citizens Capital Markets &amp; Advisory, which acted as the exclusive financial advisor to Enovis. Promus Equity Partners expressed enthusiasm about partnering with Dr. Comfort to further its mission of improving the lives of people with diabetes and other foot-related conditions.\n      </p>\n</div><div xmlns:xsd=\"http://www.w3.org/2001/XMLSchema\" xmlns:xsi=\"http://www.w3.org/2001/XMLSchema-instance\">\n<em>Disclaimer: <span>This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. <a href=\"https://laohu8.com/S/CFG\">Citizens Financial Group</a> Inc. published the original content used to generate this news brief on October 20, 2025, and is solely responsible for the information contained therein.</span></em>\n</div></body></html>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Citizens Advises Enovis on Sale of Dr. Comfort to Promus Equity Partners</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nCitizens Advises Enovis on Sale of Dr. Comfort to Promus Equity Partners\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1032215980\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time\">2025-10-20 21:26</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html xmlns=\"http://www.w3.org/1999/xhtml\" xmlns:newsg2=\"http://iptc.org/std/nar/2006-10-01/\" xmlns:xhtml=\"http://www.w3.org/1999/xhtml\"><head><title>\n      Citizens Advises Enovis on Sale of Dr. Comfort to Promus Equity Partners\n    </title></head><body><div xmlns:xsd=\"http://www.w3.org/2001/XMLSchema\" xmlns:xsi=\"http://www.w3.org/2001/XMLSchema-instance\">\n<p>\n        <a href=\"https://laohu8.com/S/ENOV\">Enovis Corporation</a> has completed the sale of its subsidiary, Dr. Comfort, to Promus Equity Partners. Dr. Comfort, founded in 2002 and based in Mequon, Wisconsin, is a leading manufacturer and provider of orthopedic and diabetic footwear, including shoes, inserts, socks, slippers, sandals, and compression hosiery. The transaction was supported by Citizens Capital Markets &amp; Advisory, which acted as the exclusive financial advisor to Enovis. Promus Equity Partners expressed enthusiasm about partnering with Dr. Comfort to further its mission of improving the lives of people with diabetes and other foot-related conditions.\n      </p>\n</div><div xmlns:xsd=\"http://www.w3.org/2001/XMLSchema\" xmlns:xsi=\"http://www.w3.org/2001/XMLSchema-instance\">\n<em>Disclaimer: <span>This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. <a href=\"https://laohu8.com/S/CFG\">Citizens Financial Group</a> Inc. published the original content used to generate this news brief on October 20, 2025, and is solely responsible for the information contained therein.</span></em>\n</div></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK4082","symbol_name":"医疗保健设备","start_time":0,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251020:nNDL3t8CFZ:1","article_id":"2576857633","we_media_id":"1032215980","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2576857633","pubTimestamp":1760966767,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Reuters","introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"id":"1032215980","head_image":"https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48"},"summary":"Enovis Corporation has completed the sale of its subsidiary, Dr. Comfort, to Promus Equity Partners. Dr. Comfort, founded in 2002 and based in Mequon, Wisconsin, is a leading manufacturer and provider of orthopedic and diabetic footwear, including shoes, inserts, socks, slippers, sandals, and compression hosiery. The transaction was supported by Citizens Capital Markets & Advisory, which acted as the exclusive financial advisor to Enovis. Promus Equity Partners expressed enthusiasm about partnering with Dr. Comfort to further its mission of improving the lives of people with diabetes and other foot-related conditions.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Citizens Financial Group Inc. published the original content used to gen","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"BK4082":"医疗保健设备","LU2237438978.USD":"Amundi Funds US Pioneer A2 (C) USD","LU2065732104.USD":"ALLSPRING (LUX) WF GLOBAL SMALL CAP EQUITY \"I\" (USD) ACC","LU0661504455.SGD":"Blackrock Global Equity Income A5 SGD-H","LU1791807156.HKD":"BGF WORLD FINANCIALS \"A2\" (HKDHDG) ACC","LU1668664300.SGD":"Blackrock World Financials A2 SGD-H","LU0949170772.SGD":"Blackrock Global Equity Income A6 SGD-H","CFG":"Citizens Financial Group","LU0738911758.USD":"Blackrock Global Equity Income A6 USD","LU0106831901.USD":"贝莱德世界金融基金A2","IE00B19Z6F94.USD":"Legg Mason Royce - US Smaller Companies A Acc USD","BK4211":"区域性银行","IE0034390439.USD":"FTGF ROYCE US SMALLER COMPANIES \"A\" (USD) D","ENOV":"Enovis Corporation","BK4588":"碎股","BK4585":"ETF&股票定投概念"},"translate_title":"Citizens为Enovis将Dr.Comfort出售给Promus Equity Partners提供建议","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"CFG":0.9,"ENOV":0.9},"content_text":"Citizens Advises Enovis on Sale of Dr. Comfort to Promus Equity Partners\n    \n\nEnovis Corporation has completed the sale of its subsidiary, Dr. Comfort, to Promus Equity Partners. Dr. Comfort, founded in 2002 and based in Mequon, Wisconsin, is a leading manufacturer and provider of orthopedic and diabetic footwear, including shoes, inserts, socks, slippers, sandals, and compression hosiery. The transaction was supported by Citizens Capital Markets & Advisory, which acted as the exclusive financial advisor to Enovis. Promus Equity Partners expressed enthusiasm about partnering with Dr. Comfort to further its mission of improving the lives of people with diabetes and other foot-related conditions.\n      \n\nDisclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Citizens Financial Group Inc. published the original content used to generate this news brief on October 20, 2025, and is solely responsible for the information contained therein.","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"}}}